Focused Alpha’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$635K Sell
10,178
-75
-0.7% -$4.74K 0.16% 120
2026
Q2
$591K Buy
10,253
+1,882
+22% +$108K 0.15% 135
2026
Q1
$508K Buy
+8,371
New +$488K 0.16% 131

Other funds holding BMY

Focused Alpha's BMY Position: Q3 2026 in Review

Focused Alpha reduced its Bristol-Myers Squibb (BMY) stake by 0.73% in Q3 2026, selling an estimated $4.74K and leaving 10,178 shares worth $635K. The position accounts for 0.16% of the portfolio, ranked #120.

Focused Alpha first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Focused Alpha held 10,178 shares of Bristol-Myers Squibb worth $635K as of Q3 2026.
  • Focused Alpha sold 75 Bristol-Myers Squibb shares in Q3 2026, an estimated $4.74K.
  • Bristol-Myers Squibb made up 0.16% of Focused Alpha's portfolio in Q3 2026, its #120 holding.
  • Focused Alpha first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.